Determination of picropodophyllin and its isomer podophyllotoxin in human serum samples with electrospray ionization of hexylamine adducts by liquid chromatography–tandem mass spectrometry

A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensit...

Full description

Saved in:
Bibliographic Details
Published inJournal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 879; no. 5; pp. 326 - 334
Main Authors Rönquist-Nii, Yuko, Eksborg, Staffan, Axelson, Magnus, Harmenberg, Johan, Beck, Olof
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 15.02.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/ z 516 → 102 for picropodophyllin and podophyllotoxin and m/ z 500 → 102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC–MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.
AbstractList A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1mm×50mm 1.7μm column with gradient elution (mobile phase A: 2.5mM hexylamine and 5mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4min for picropodophyllin, 1.5min for podophyllotoxin and 1.9min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01μmol/L and 5μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC–MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.
A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/ z 516 → 102 for picropodophyllin and podophyllotoxin and m/ z 500 → 102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC–MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm x 50 mm 1.7 mu m column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516 --> 102 for picropodophyllin and podophyllotoxin and m/z 500 --> 102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 mu mol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 mu mol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 mu mol/L and 5 mu mol/L for both isomers. The accuracy was within +/-15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed +/-15%, except for the 0.016 mu mol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEN C18, 2.1 mm x 50 mm 1.7 mu m column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Qwater and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516 --> 102 for picropodophyllin and podophyllotoxin and m/z 500 --> 102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 mu mol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 mu mol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 mu mol/L and 5 mu mol/L for both isomers. The accuracy was within +/-15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed +/-15%, except for the 0.016 mu mol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.
Author Beck, Olof
Axelson, Magnus
Eksborg, Staffan
Rönquist-Nii, Yuko
Harmenberg, Johan
Author_xml – sequence: 1
  givenname: Yuko
  surname: Rönquist-Nii
  fullname: Rönquist-Nii, Yuko
  email: yuko.ronquist@karolinska.se
  organization: Department of Clinical Pharmacology, Karolinska University Hospital, SE-141 86 Stockholm, Sweden
– sequence: 2
  givenname: Staffan
  surname: Eksborg
  fullname: Eksborg, Staffan
  organization: Karolinska Institutet, Stockholm, Sweden
– sequence: 3
  givenname: Magnus
  surname: Axelson
  fullname: Axelson, Magnus
  organization: Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden
– sequence: 4
  givenname: Johan
  surname: Harmenberg
  fullname: Harmenberg, Johan
  organization: Axelar AB, Karolinska Institutet Science Park, SE-171 65 Solna, Sweden
– sequence: 5
  givenname: Olof
  surname: Beck
  fullname: Beck, Olof
  organization: Department of Clinical Pharmacology, Karolinska University Hospital, SE-141 86 Stockholm, Sweden
BackLink https://cir.nii.ac.jp/crid/1572543024858732032$$DView record in CiNii
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23877291$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21251888$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-173947$$DView record from Swedish Publication Index
http://kipublications.ki.se/Default.aspx?queryparsed=id:122017788$$DView record from Swedish Publication Index
BookMark eNqFkttu1DAQhiNURA_wCIAvQHDBLj7EjldcoKrlJFXigoK4sxxn0vWSxKmd0C5XvAPvw8PwJMweWiQkqBQ5lv3N_OOZfz_b6UIHWXaf0SmjTD1fTBduHkNbTjldnfEpZcWtbI_pQkxEoT7v4F4WdEK54LvZfkoLigQtxJ1slzMumdZ6L_t5DAPE1nd28KEjoSa9dzH0oQr9fNk0viO2q4gfEvEptBDJ9VUYwiVe4zcfW9uRBHFsSbJt30AiF36YE2jADTGkPtolwfz-27XMHC6XjUVhILaqRocC5ZI0_nz0FVm_zA7hLFqU-vX9x4BFQEtamxJJ_TppC0Nc3s1u17ZJcG_7P8hOX786PXo7OXn_5t3R4cnESV0ME1s7KBUtK61y7ljtZpLrAoqcY4t0XVYsB8ehsppJcFBLauuSsVLNnKQ1EwfZZJM2XUA_lqaPvrVxaYL1Znv0BXdgZK4UFcg_-yd_7D8dmhDPzDgaVohZXiD-ZIP3MZyPkAbT-uSgaWwHYUxGKyaVRvRmUlKpBBernE__SzKlhBIy1xTRB1t0LFuorqu9cgkCj7eATc42dbSd8-kPJ3RR8NmqTS82HDoopQi1cX5YT3yI1jeGUbPyrlmYrXfNyruGcYPOxGj5V_SVwE1xjzZxnfcouFpxqlzmgvJc4_wFp9iSg-zhBqttMPYs4gM-fsA8klJaKLZu7ssNAeikrx6iSc5D56DyES1nquBvKOU3Djgneg
CitedBy_id crossref_primary_10_1002_slct_202305100
crossref_primary_10_1016_j_molliq_2020_114258
crossref_primary_10_1021_acs_chemrev_8b00504
crossref_primary_10_1158_1535_7163_MCT_13_0091
crossref_primary_10_1002_bmc_3066
crossref_primary_10_1016_j_jelechem_2020_114439
crossref_primary_10_3109_0284186X_2015_1049290
crossref_primary_10_1016_j_jct_2021_106668
crossref_primary_10_1039_C4NP00064A
crossref_primary_10_3390_cancers12040793
ContentType Journal Article
Copyright 2010 Elsevier B.V.
2015 INIST-CNRS
Copyright © 2010 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2010 Elsevier B.V.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2010 Elsevier B.V. All rights reserved.
DBID FBQ
RYH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7S9
L.6
7X8
7TB
8FD
FR3
ADTPV
AOWAS
DF2
DOI 10.1016/j.jchromb.2010.12.017
DatabaseName AGRIS
CiNii Complete
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
Mechanical & Transportation Engineering Abstracts
Technology Research Database
Engineering Research Database
SwePub
SwePub Articles
SWEPUB Uppsala universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
Technology Research Database
Mechanical & Transportation Engineering Abstracts
Engineering Research Database
DatabaseTitleList

MEDLINE - Academic
Technology Research Database

MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1873-376X
EndPage 334
ExternalDocumentID oai_swepub_ki_se_546603
oai_DiVA_org_uu_173947
21251888
23877291
10_1016_j_jchromb_2010_12_017
10029516781
US201500076194
S1570023210007737
Genre Journal Article
GroupedDBID --K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29K
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AAXUO
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFS
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AI.
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
D-I
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
RIG
RNS
ROL
RPZ
SCB
SCC
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SSK
SSU
SSZ
T5K
VH1
XFK
ZGI
~G-
AATTM
AAXKI
AEIPS
AFJKZ
ANKPU
BNPGV
FBQ
SSH
AAYWO
AGCQF
AGRNS
AIIUN
RYH
AAYXX
CITATION
APXCP
EFKBS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7S9
L.6
7X8
7TB
8FD
FR3
ADTPV
AOWAS
DF2
ID FETCH-LOGICAL-c587t-afceb60bd8642c1fc95287e7421578fbd14ec2eda815ecef50afb11b69c50f13
IEDL.DBID .~1
ISSN 1570-0232
1873-376X
IngestDate Mon Sep 01 03:36:11 EDT 2025
Thu Aug 21 06:28:52 EDT 2025
Fri Jul 11 16:13:58 EDT 2025
Tue Aug 05 11:13:15 EDT 2025
Thu Jul 10 22:20:30 EDT 2025
Mon Jul 21 05:52:07 EDT 2025
Mon Jul 21 09:14:16 EDT 2025
Tue Jul 01 01:50:04 EDT 2025
Thu Apr 24 22:51:21 EDT 2025
Thu Jun 26 23:27:42 EDT 2025
Thu Apr 03 09:44:09 EDT 2025
Fri Feb 23 02:21:37 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human serum
Hexylamine adduct
LC–MS/MS
Picropodophyllin
Antineoplastic agent
Human
Biological fluid
Podophyllotoxin
HPLC chromatography
Determination
Electrospray
Isomer
Mass spectrometry MS/MS
LC―MS/MS
Lignan
Hexylamine
Antimitotic
Molecular adduct
Quantitative analysis
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2010 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c587t-afceb60bd8642c1fc95287e7421578fbd14ec2eda815ecef50afb11b69c50f13
Notes http://dx.doi.org/10.1016/j.jchromb.2010.12.017
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 21251888
PQID 1663635480
PQPubID 24069
PageCount 9
ParticipantIDs swepub_primary_oai_swepub_ki_se_546603
swepub_primary_oai_DiVA_org_uu_173947
proquest_miscellaneous_861568394
proquest_miscellaneous_850563237
proquest_miscellaneous_1663635480
pubmed_primary_21251888
pascalfrancis_primary_23877291
crossref_citationtrail_10_1016_j_jchromb_2010_12_017
crossref_primary_10_1016_j_jchromb_2010_12_017
nii_cinii_1572543024858732032
fao_agris_US201500076194
elsevier_sciencedirect_doi_10_1016_j_jchromb_2010_12_017
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-02-15
PublicationDateYYYYMMDD 2011-02-15
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-15
  day: 15
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
PublicationTitleAlternate J Chromatogr B Analyt Technol Biomed Life Sci
PublicationYear 2011
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Gualberto, Pollak (bib0010) 2009; 10
Zhao, Liu, Fan (bib0020) 2009; 32
Tashima, Kondo, Meada, Oda, Hagimoto, Tsukuda, Yushimura (bib0045) 2002; 37
Razuvaev, Henderson, Girnita, Larsson, Axelson, Hedin, Roy (bib0025) 2007; 46
Gao, Zhang, Karnes (bib0040) 2005; 825
Mortier, Zhang, Van Peterghem, Lambert (bib0050) 2004; 15
Pollak (bib0015) 2008; 8
Shah, Midha, Findlay, Hill, Hulse, McGilveray, McKay, Miller, Patnailk, Powell, Tonelli, Viswanathan, Yacobi (bib0030) 2000; 825
Food Drug Administration (bib0035) 2001
Girnita, Girnita, del Prete, Bartolazzi, Larsson, Axelson (bib0005) 2004; 64
Stefansson, Sjöberg, Markides (bib0055) 1996; 68
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:148
References_xml – year: 2001
  ident: bib0035
  article-title: Guidance for Industry: Bioanalytical Methods Validation
– volume: 46
  start-page: 108
  year: 2007
  ident: bib0025
  publication-title: J. Vasc. Surg.
– volume: 32
  start-page: 1323
  year: 2009
  ident: bib0020
  publication-title: J. Sep. Sci.
– volume: 37
  start-page: 631
  year: 2002
  ident: bib0045
  publication-title: J. Mass Spectrom.
– volume: 68
  start-page: 1792
  year: 1996
  ident: bib0055
  publication-title: Anal. Chem.
– volume: 10
  start-page: 923
  year: 2009
  ident: bib0010
  publication-title: Curr. Drug Targets
– volume: 825
  start-page: 1551
  year: 2000
  ident: bib0030
  publication-title: Pharmaceut. Res. B
– volume: 15
  start-page: 585
  year: 2004
  ident: bib0050
  publication-title: J. Am. Soc. Mass Spectrom.
– volume: 8
  start-page: 915
  year: 2008
  ident: bib0015
  publication-title: Nat. Rev. Cancer
– volume: 825
  start-page: 98
  year: 2005
  ident: bib0040
  publication-title: J. Chromatogr. B
– volume: 64
  start-page: 236
  year: 2004
  ident: bib0005
  publication-title: Cancer Res.
– reference: - J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:148
SSID ssj0017073
Score 2.0416338
Snippet A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer...
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer...
SourceID swepub
proquest
pubmed
pascalfrancis
crossref
nii
fao
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 326
SubjectTerms acetonitrile
Adducts
Adult
Aged, 80 and over
Amines
Amines - chemistry
analogs & derivatives
Analysis
Analytical, structural and metabolic biochemistry
Animals
antineoplastic agents
Biological and medical sciences
blood
blood serum
chemistry
Chromatography
Chromatography, Liquid
Chromatography, Liquid - methods
detection limit
Drug Stability
Female
formic acid
Fundamental and applied biological sciences. Psychology
General pharmacology
Hexylamine adduct
Human
Human serum
Humans
Ionization
ions
Isomers
LC-MS
LC–MS/MS
Least-Squares Analysis
liquid chromatography
Liquids
Male
Medical sciences
methanol
methods
Mice
monitoring
pharmacokinetics
Pharmacology. Drug treatments
Picropodophyllin
Podophyllotoxin
Podophyllotoxin - analogs & derivatives
Podophyllotoxin - analysis
Podophyllotoxin - blood
Podophyllotoxin - pharmacokinetics
Reproducibility of Results
Sensitivity and Specificity
Serums
Spectrometry, Mass, Electrospray Ionization
Spectrometry, Mass, Electrospray Ionization - methods
Swine
Tandem Mass Spectrometry
Title Determination of picropodophyllin and its isomer podophyllotoxin in human serum samples with electrospray ionization of hexylamine adducts by liquid chromatography–tandem mass spectrometry
URI https://dx.doi.org/10.1016/j.jchromb.2010.12.017
https://cir.nii.ac.jp/crid/1572543024858732032
https://www.ncbi.nlm.nih.gov/pubmed/21251888
https://www.proquest.com/docview/1663635480
https://www.proquest.com/docview/850563237
https://www.proquest.com/docview/861568394
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-173947
http://kipublications.ki.se/Default.aspx?queryparsed=id:122017788
Volume 879
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGeOEFAQMWYJWRYG9Z41zdx6pjKhdNiG1ob1bi2Fu6JSm5SCsPiP_A_-HH8Es4J7dpqDAJqUorX2rX_nr8-fj4HEJeBR5TtiUd0_NVbLrSluYklpHJYbEINHB8pRoD2UN_fuK-O_VON8isvwuDZpWd7G9leiOtu5RxN5rjZZKMjxi6ZrfxDgr6pHHwRrnrBojyvW-DmQcLrOaUGQubWPr6Fs94sbeQ50WeRq2FF2oFm7hla9enOzrM4ZklCZpPhiWMoG5DX6zjpn84Hm0Wq4MH5H7HMum0_SEPyYbKHpGtaQY77HRFd2lj99ko1LfIz_3eIgbniOaaLtFIbwn7VZgCdNlNwyymSVXSpMxTVdAhK6_yK8iGVxPqjwKc65SWIXocLimqeGkXZqdcFuGKou7369DMubpaAR6B5lIQf7WEBqIVvUy-1ElMmyGD7rYOtX99_4EqD5XSFMg-ba6Hop-Fqlg9JscHb45nc7OL6mBKjweVGWqpIt-KYg5bH8m0nHiwa1OwRYc54jqKmaukreKQM09JpT0r1BFjkT-RnqWZ84RsZnmmtgnVStkxgC2EdFfG3kTG2ouQUk78UHNlELefSiE7j-cYeONS9KZtC9EhQCACBLMFIMAge0O1Zevy47YKvMeJuIFdAcvSbVW3AVciPAOJLk6ObNQ_Wa1qySA7ADboOD5haNBrQeOAjgcOhr03yOgGDIe-AgnDLRMzyMselwJkBh4EhZnK61IwoJlANF1uGYT-pQxHauzYTvCPIsCGfSDY0NWnLeyv-4C8mXNukNft_2DIQXfm-8nnqciLM1HXggXwBdDI7ppyXdIFfFLCc33fcp79_1g_J_faAwHbZN4LslkVtdoBRllFo0ZkjMjd6ezTh4_4_vb9_PA3aFZ9Pw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLa27gJuEDBgATaMBLvLGidx4l5WG1PHRm-2od1ZiWNvKWtSmkRaueIdeB8ehifhnPx0GipMQqqiyrET1_56_Pn4-DMh70LOtOsoz-aBTmxfucoeJCq2BQwWoQGOr3UdIDsORuf-xwt-sUb2u70wGFbZ2v7GptfWuk3pt63Zn6Vp_5ShNLuLe1BQk8YL18kGqlPxHtkYHh2PxsvFhNCpF5oxv40Fbjfy9Cd7E3U1z6dxE-SFjsH66LKVQ9S6iXK4ZmmKEZRRAY1omtMvVtHTP7RH6_Hq8DF51BJNOmx-yxOyprOnZHOYwSR7uqC7tA79rH3qm-TnQRcUg91Ec0NnGKc3gykr9AKqdtMoS2haFjQt8qme0-WtvMxv4DZ86tP-KCC6mtIiQtHhgqKXl7Yn7RSzebSg6P79tnzNlb5ZACSB6VKwgJWCF8QLep1-rdKE1k0G1W00tX99_4FeDz2lU-D7tN4hilIL5XzxjJwdfjjbH9ntwQ624iIs7cgoHQdOnAiY_Shm1IDDxE3DLB36SJg4Yb5Wrk4iwbhW2nAnMjFjcTBQ3DHMe056WZ7pLUKN1m4CeIsg3VcJH6jE8BhZ5SCIjNAW8buulKoVPcezN65lF902kS0CJCJAMlcCAiyytyw2a1Q_7isgOpzIO_CVMDLdV3QLcCWjSzDq8vzURReU03iXLLINYIOK4xWaBoULag06EXqu47kW2bkDw2VdgYfhrIlZ5G2HSwlmA9eCokznVSEZME3gmr5wLEL_kkcgO_ZcL_xHFiDEAXBsqOqLBva3dUDqLISwyPvmf7C8g4rmB-nnocznl7KqJAvhAfCS3RX52qQv8E1L7geB4738_7Z-Qx6Mzj6dyJOj8fEr8rBZH3Btxl-TXjmv9DYQzDLeaQ3Ibzshfls
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determination+of+picropodophyllin+and+its+isomer+podophyllotoxin+in+human+serum+samples+with+electrospray+ionization+of+hexylamine+adducts+by+liquid+chromatography-tandem+mass+spectrometry&rft.jtitle=Journal+of+chromatography.+B%2C+Analytical+technologies+in+the+biomedical+and+life+sciences&rft.au=Ronquist-Nii%2C+Y&rft.au=Eksborg%2C+S&rft.au=Axelson%2C+M&rft.au=Harmenberg%2C+J&rft.date=2011-02-15&rft.issn=1570-0232&rft.volume=879&rft.issue=5-6&rft.spage=326&rft_id=info:doi/10.1016%2Fj.jchromb.2010.12.017&rft.externalDocID=oai_swepub_ki_se_546603
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1570-0232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1570-0232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1570-0232&client=summon